AUTOIMMUNITY

Scope & Guideline

Pioneering insights into autoimmune diseases.

Introduction

Welcome to the AUTOIMMUNITY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of AUTOIMMUNITY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0891-6934
PublisherTAYLOR & FRANCIS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 1988 to 2024
AbbreviationAUTOIMMUNITY / Autoimmunity
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The journal 'AUTOIMMUNITY' focuses on the complexities of autoimmune diseases and their mechanisms, providing a platform for innovative research that explores both fundamental and applied aspects of autoimmunity. It aims to bridge clinical and laboratory research to enhance understanding and treatment of autoimmune conditions.
  1. Autoimmune Mechanisms and Pathways:
    The journal emphasizes research on the underlying mechanisms of autoimmune diseases, including the roles of immune cells, cytokines, and signaling pathways. This includes studies on molecular interactions and the impact of genetic and environmental factors on autoimmunity.
  2. Animal Models in Autoimmunity Research:
    A significant focus is on the development and use of animal models to study autoimmune diseases. These models help to elucidate disease mechanisms and evaluate potential therapeutic interventions.
  3. Biomarkers and Therapeutic Targets:
    Research is directed toward identifying biomarkers for autoimmune diseases and understanding their clinical implications. Additionally, the journal reports on novel therapeutic targets and strategies for managing autoimmune conditions.
  4. Role of MicroRNAs and Non-coding RNAs:
    The journal investigates the involvement of microRNAs and other non-coding RNAs in the regulation of immune responses and their potential as therapeutic targets in autoimmune diseases.
  5. Clinical Studies and Epidemiology:
    It also publishes clinical studies that explore the epidemiology, diagnosis, and treatment of autoimmune diseases, contributing valuable insights to improve patient care.
In recent years, 'AUTOIMMUNITY' has seen a rise in interest in several emerging themes that reflect current trends in autoimmune research. These trends highlight the evolving understanding of autoimmune diseases and their treatment.
  1. Role of Gut Microbiota:
    There is an increasing focus on the role of gut microbiota in autoimmune diseases, suggesting that microbial composition can influence disease onset and progression. This emerging theme is crucial for understanding the gut-immune system relationship.
  2. Inflammasomes and Pyroptosis:
    Research on inflammasomes, particularly the NLRP3 inflammasome, and the process of pyroptosis is gaining traction. These studies are relevant for understanding inflammatory mechanisms in autoimmune diseases.
  3. Non-coding RNAs in Autoimmunity:
    The exploration of non-coding RNAs, including microRNAs and circular RNAs, is trending. Their regulatory roles in immune responses and potential as therapeutic targets are becoming increasingly recognized.
  4. Integrative Approaches to Autoimmunity:
    There is a growing emphasis on integrative approaches that combine immunology, genetics, and environmental factors to understand autoimmune diseases. This trend reflects a more holistic view of disease mechanisms.
  5. Impact of COVID-19 on Autoimmunity:
    Research examining the intersection of COVID-19 and autoimmune diseases is emerging, particularly concerning vaccine responses and the long-term effects of viral infections on autoimmune conditions.

Declining or Waning

While 'AUTOIMMUNITY' continues to explore a broad range of topics, certain areas of research have seen a decline in focus over recent years. The following themes are becoming less prominent in recent publications, indicating a potential shift in research priorities.
  1. Traditional Autoimmunity Theories:
    Research based on traditional theories of autoimmunity, such as the purely autoimmune model without considering the role of environmental triggers or microbiome interactions, appears to be waning. There is a shift towards more integrative and holistic approaches.
  2. Conventional Pharmacological Treatments:
    Studies focusing exclusively on conventional pharmacological treatments without exploring novel therapeutic modalities, such as biologics or targeted therapies, are less frequently published. There is a growing interest in personalized medicine and alternative treatment strategies.
  3. Static Biomarker Studies:
    Research that solely identifies static biomarkers without exploring their dynamic roles in disease progression or response to treatment is declining. The focus is shifting towards understanding the functional implications of biomarkers.
  4. Basic Immunology without Disease Context:
    Basic immunological studies that do not link findings to specific autoimmune diseases or clinical outcomes are less common. The emphasis is now on translating basic research into clinical applications.

Similar Journals

FUNCTIONAL & INTEGRATIVE GENOMICS

Innovating Insights into Genetic Integration
Publisher: SPRINGER HEIDELBERGISSN: 1438-793XFrequency: 4 issues/year

FUNCTIONAL & INTEGRATIVE GENOMICS, published by Springer Heidelberg, is a leading journal in the fields of genetics and molecular biology. Established in 2000, it serves as a pivotal platform for advancing our understanding of genomic functionality and integration, making significant contributions to both basic and applied research in genetics. With a robust impact factor and a ranking in the Q3 quartile for Genetics and Q2 for Medicine (Miscellaneous), the journal aims to publish innovative research that explores the relationships between genomic data and biological functions, appealing to a diverse audience of researchers and professionals. Although it operates under a subscription model, the journal's extensive archives remain a valuable resource for academics seeking to stay abreast of the latest findings and methodologies in genomics. As the field evolves, FUNCTIONAL & INTEGRATIVE GENOMICS remains committed to fostering scholarly dialogue and the dissemination of groundbreaking studies that influence future research trajectories.

AIMS Allergy and Immunology

Pioneering Insights for Immune Health
Publisher: AMER INST MATHEMATICAL SCIENCES-AIMSISSN: 2575-615XFrequency: 4 issues/year

AIMS Allergy and Immunology is a prestigious open access journal dedicated to advancing knowledge in the fields of allergy and immunology. Published by the American Institute of Mathematical Sciences (AIMS), this journal provides a vibrant platform for researchers, practitioners, and scholars to share groundbreaking findings and insights. Recognized for its commitment to disseminating high-quality research since its inception in 2017, AIMS Allergy and Immunology contributes significantly to the understanding of complex immunological mechanisms and allergic responses, thus playing a pivotal role in enhancing clinical practices and therapeutic strategies. With its ISSN 2575-615X, the journal aims to facilitate a robust exchange of ideas and promote collaboration within the scientific community. Researchers and practitioners are encouraged to access the latest studies and reviews, which are all freely available online, ensuring that vital information reaches a global audience without barriers. Together, we can tackle the challenges posed by allergies and immune disorders through rigorous scientific inquiry and innovation.

ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY

Bridging the gap between research and clinical practice.
Publisher: ALLERGY IMMUNOL SOC THAILANDISSN: 0125-877XFrequency: 4 issues/year

The ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, published by the Allergy Immunology Society of Thailand, is a pivotal platform for disseminating high-quality research in the fields of allergy and immunology. Established in 1983, this journal has consistently evolved to address the pressing challenges and advancements in these dynamic disciplines, contributing significantly to the global scientific community's understanding of immunological disorders. With a category ranking of Q3 in Immunology and Allergy, and Q2 in Medicine (miscellaneous) for 2023, the journal stands at the forefront of impactful research, engaging with a diverse audience of researchers, clinicians, and students alike. Although it operates on a non-open access model, its rigorous peer-review process ensures that published articles meet the highest academic standards. Located in Bangkok, Thailand, the journal connects researchers across the Asia-Pacific region, fostering collaboration and innovation to enhance patient care in the realm of allergy and immunology.

Non-Coding RNA

Pioneering Discoveries in Non-Coding RNA Biology
Publisher: MDPIISSN: Frequency: 6 issues/year

Non-Coding RNA is a prestigious open-access journal published by MDPI, based in Switzerland, dedicated to the significant and rapidly evolving field of non-coding RNA research. Established in 2015, this journal has quickly become an essential resource for researchers and professionals, showcasing innovative studies and breakthroughs related to the functions and mechanisms of non-coding RNAs in various biological processes. With an impressive Q1 ranking in Biochemistry and strong rankings in Genetics and Molecular Biology, Non-Coding RNA consistently reflects the highest standards of academic publishing. The journal provides comprehensive access options, granting researchers worldwide the ability to disseminate and access high-quality research without subscription barriers. As the landscape of genomics and molecular discoveries continues to expand, the journal aims to foster interdisciplinary exchanges and collaborations, making it a vital platform for advancing knowledge and innovation in this critical area of biological science.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Pioneering research for a healthier tomorrow.
Publisher: SPANDIDOS PUBL LTDISSN: 1107-3756Frequency: 12 issues/year

International Journal of Molecular Medicine is a prestigious publication dedicated to advancing the field of molecular medicine through innovative research and scholarly dialogue. Published by Spandidos Publications Ltd in Greece, this journal has successfully provided a platform for academics and professionals alike since its inception in 1998. With an impressive 2023 Q1 ranking in Medicine (Miscellaneous) and a Q2 ranking in Genetics, the journal maintains a vital role in disseminating high-quality research, underscored by its strong performance in the Scopus rankings, particularly in the realm of genetics where it ranks 28 out of 347. Researchers will benefit from its comprehensive scope, which encompasses a wide range of topics within molecular biology, genetics, and their clinical applications. Although the journal does not operate under an open access model, it remains influential, providing critical insights that contribute significantly to the understanding and development of molecular therapeutic strategies and innovations.

Rheumatology & Autoimmunity

Exploring the frontiers of autoimmune research.
Publisher: WILEYISSN: 2767-1410Frequency: 4 issues/year

Rheumatology & Autoimmunity, published by WILEY, is an emerging academic journal that delves into the intricacies of rheumatological diseases and autoimmune disorders, providing a critical platform for researchers and practitioners within the field. With an ISSN of 2767-1410 and E-ISSN 2767-1429, the journal aims to disseminate cutting-edge research in both clinical and laboratory settings, enhancing knowledge and understanding among professionals and scholars. Although currently classified in Q4 for Immunology and Allergy, and Q3 for Internal Medicine and Rheumatology as of 2023, the journal is positioned for growth and greater visibility in the scientific community. The three-year publishing span from 2021 to 2024 signifies a commitment to addressing contemporary issues and fostering collaboration among various disciplines related to immunology. As an open access journal, it provides wide accessibility, ensuring that groundbreaking research is available to a broad audience. This journal is poised to become a vital resource for those dedicated to advancing the understanding and treatment of autoimmune conditions.

Molecular Medicine Reports

Elevating Knowledge in Molecular Medicine
Publisher: SPANDIDOS PUBL LTDISSN: 1791-2997Frequency: 12 issues/year

Molecular Medicine Reports, an esteemed academic journal published by Spandidos Publications Ltd, serves as a vital platform for the dissemination of cutting-edge research in the field of molecular medicine. Established in 2008, this journal has rapidly ascended in prominence, currently positioned within the Q2 and Q3 quartiles across various critical categories including Biochemistry, Cancer Research, and Genetics, reflecting its significant impact and scholarly contributions. With an impressive Scopus ranking in multiple disciplines, including an 87th place in Oncology, it is recognized for publishing rigorous, peer-reviewed articles that bridge the gap between laboratory research and clinical applications. The journal’s commitment to advancing knowledge in molecular medicine is evident through its focus on innovative therapeutic approaches, genetic research, and oncological studies, catering to a diverse readership of researchers, professionals, and students in the biomedical field. Though not an open-access publication, it provides invaluable insights and fosters collaboration in the scientific community from its base in Athens, Greece.

Central European Journal of Immunology

Pioneering Discoveries in Allergy and Immunology
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1426-3912Frequency: 4 issues/year

Central European Journal of Immunology is a premier publication dedicated to advancing the field of immunology and allergy research. Established in 1996 and published by TERMEDIA PUBLISHING HOUSE LTD, this open access journal has consistently provided a platform for innovative research and comprehensive reviews since its transition to open access in 2002. With an ISSN of 1426-3912 and E-ISSN of 1644-4124, it embraces a global readership while being rooted in Poland. The journal, with a notable Q3 ranking in both the categories of immunology and allergy in 2023, positions itself within the competitive landscape of scientific discourse, as reflected in its Scopus rankings. Designed for researchers, professionals, and students, the Central European Journal of Immunology not only disseminates significant findings but also fosters collaboration and innovation in the immunological sciences, making it a vital resource for those seeking to stay current in this rapidly evolving field.

Immunological Medicine

Exploring the Frontiers of Immune Health
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 4 issues/year

Immunological Medicine, published by Taylor & Francis Ltd, is an esteemed open-access journal that has made significant strides in the field of immunology since its establishment in 2018. With an E-ISSN of 2578-5826, the journal has quickly gained recognition for its contribution to advancing immunological research, evidenced by its impressive ranking in the Q2 quartile for both immunology and allergy. Positioned in the United Kingdom, it offers a platform for publishing high-quality original research, reviews, and case studies that delve into the complex interactions of the immune system and its implications for human health. The journal serves as a vital resource for researchers, professionals, and students engaged in the burgeoning fields of immunology, providing open access to a wide audience and fostering collaboration and innovation. With a current Scopus ranking of #81 out of 233 in Immunology and Allergy and #97 out of 236 in Immunology and Microbiology, the journal aims to enhance the visibility and impact of cutting-edge research by bridging the gap between academia and clinical practice.

Turkish Journal of Immunology

Exploring the Frontiers of Immunology Research
Publisher: GALENOS PUBL HOUSEISSN: 1301-109XFrequency: 3 issues/year

Turkish Journal of Immunology, published by GALENOS PUBL HOUSE, is a key platform for research in the field of immunology, with ISSN 1301-109X and E-ISSN 2147-8325. Established to foster the dissemination of original research, critical reviews, and cutting-edge developments, this journal spans a wide array of immunological topics, aiming to keep researchers, healthcare professionals, and students abreast of emergent trends and findings. Although classified in the Q4 quartile within both the Immunology and Allergy categories, the journal provides an essential venue for underrepresented research, paving the way for innovative ideas and collaborations. The editorial board emphasizes a rigorous peer-review process, ensuring the highest standards in the publication of quality science. For those keen to explore the intricacies of immunity, the Turkish Journal of Immunology is not to be missed.